Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Prostate Cancer

Free Subscription Articles published in Radiology Retrieve available abstracts of 30 articles: HTML format

Single Articles

January 2022
1. KANAS AF, Fenelon SS, Santos JMMM, Coelho RF, et al
   Case 297: Mucinous Adenocarcinoma of the Prostate.
   Radiology. 2022;302:238-242.
   PubMed     Abstract available
   
   
   December 2021
2. GOTTLIEB RH
   Introducing a Standard in Prostate Cancer Imaging Evaluation.
   Radiology. 2021 Dec 21:212111. doi: 10.1148/radiol.212111.
   PubMed    
   
   
   
3. WIBMER AG, Nikolovski I, Chaim J, Lakhman Y, et al
   Local Extent of Prostate Cancer at MRI versus Prostatectomy Histopathology: Associations with Long-term Oncologic Outcomes.
   Radiology. 2021 Dec 21:210875. doi: 10.1148/radiol.210875.
   PubMed     Abstract available
   
   
   November 2021
4. WILLIAMS HT, Estes TL
   Anatomic and Functional Prostate Cancer Imaging.
   Radiology. 2021;301:E418.
   PubMed    
   
   
   October 2021
5. KANG SK, Mali RD, Prabhu V, Ferket BS, et al
   Active Surveillance Strategies for Low-Grade Prostate Cancer: Comparative Benefits and Cost-effectiveness.
   Radiology. 2021;301:E380.
   PubMed    
   
   
   August 2021
6. WILLIAMS HT, Estes TL
   Anatomic and Functional Prostate Cancer Imaging.
   Radiology. 2021 Aug 31:211837. doi: 10.1148/radiol.2021211837.
   PubMed    
   
   
   
7. MARGEL D, Bernstine H, Groshar D, Ber Y, et al
   Diagnostic Performance of (68)Ga Prostate-specific Membrane Antigen PET/MRI Compared with Multiparametric MRI for Detecting Clinically Significant Prostate Cancer.
   Radiology. 2021 Aug 31:204093. doi: 10.1148/radiol.2021204093.
   PubMed     Abstract available
   
   
   July 2021
8. KANG SK, Mali RD, Prabhu V, Ferket BS, et al
   Active Surveillance Strategies for Low-Grade Prostate Cancer: Comparative Benefits and Cost-effectiveness.
   Radiology. 2021 Jul 13:204321. doi: 10.1148/radiol.2021204321.
   PubMed     Abstract available
   
   
   May 2021
9. DENIFFEL D, Healy GM, Dong X, Ghai S, et al
   Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer.
   Radiology. 2021 May 25:204112. doi: 10.1148/radiol.2021204112.
   PubMed     Abstract available
   
   
   
10. LI M, Guo J, Hu P, Jiang H, et al
    Tomoelastography Based on Multifrequency MR Elastography for Prostate Cancer Detection: Comparison with Multiparametric MRI.
    Radiology. 2021;299:E259.
    PubMed    
    
    
    
11. GHAI S, Finelli A, Corr K, Chan R, et al
    MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial.
    Radiology. 2021;299:E258.
    PubMed    
    
    
    
12. GOLDBERG SN
    More Interventional Oncologic Fire from COLDFIRE-2.
    Radiology. 2021;299:481-482.
    PubMed    
    
    
    April 2021
13. HARMON SA, Gesztes W, Young D, Mehralivand S, et al
    Prognostic Features of Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy Based on Multiparametric MRI and Immunohistochemistry Analysis of MRI-guided Biopsy Specimens.
    Radiology. 2021 Apr 13:202425. doi: 10.1148/radiol.2021202425.
    PubMed     Abstract available
    
    
    
14. COSTA DN
    Multiparametric MRI of the Prostate: Beyond Cancer Detection and Staging.
    Radiology. 2021 Apr 13:204506. doi: 10.1148/radiol.2021204506.
    PubMed    
    
    
    March 2021
15. JADVAR H
    Competitive Advantage of PSMA Theranostics in Prostate Cancer.
    Radiology. 2021 Mar 30:210348. doi: 10.1148/radiol.2021210348.
    PubMed    
    
    
    
16. LAWHN-HEATH C, Salavati A, Behr SC, Rowe SP, et al
    Prostate-specific Membrane Antigen PET in Prostate Cancer.
    Radiology. 2021 Mar 30:202771. doi: 10.1148/radiol.2021202771.
    PubMed     Abstract available
    
    
    
17. LI M, Guo J, Hu P, Jiang H, et al
    Tomoelastography Based on Multifrequency MR Elastography for Prostate Cancer Detection: Comparison with Multiparametric MRI.
    Radiology. 2021 Mar 9:201852. doi: 10.1148/radiol.2021201852.
    PubMed     Abstract available
    
    
    February 2021
18. TEMPANY-AFDHAL CMC
    Focal Treatment of Prostate Cancer: MRI Helps Guide the Way Forward.
    Radiology. 2021 Feb 2:204333. doi: 10.1148/radiol.2021204333.
    PubMed    
    
    
    
19. GHAI S, Finelli A, Corr K, Chan R, et al
    MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial.
    Radiology. 2021 Feb 2:202717. doi: 10.1148/radiol.2021202717.
    PubMed     Abstract available
    
    
    
20. TEMPANY-AFDHAL CMC, Padhani A, Barentsz J, Weinreb J, et al
    Perspectives and Concerns about PI-RADS and Variability.
    Radiology. 2021;298:E112.
    PubMed    
    
    
    November 2020
21. BAZARGANI S, Bandyk M, Balaji KC
    Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: What about the Negatives?
    Radiology. 2020 Nov 3:202870. doi: 10.1148/radiol.2020202870.
    PubMed    
    
    
    July 2020
22. ZUKOTYNSKI KA, Rowe SP
    Histologic Validation of (18)F-DCFPyL PET/CT with Comparison to Multiparametric MRI in Biochemically Recurrent Prostate Cancer.
    Radiology. 2020 Jul 7:202098. doi: 10.1148/radiol.2020202098.
    PubMed    
    
    
    
23. LINDENBERG L, Mena E, Turkbey B, Shih JH, et al
    Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of (18)F-DCFPyL PET/CT with Comparison to Multiparametric MRI.
    Radiology. 2020 Jul 7:192018. doi: 10.1148/radiol.2020192018.
    PubMed     Abstract available
    
    
    
24. MILOT L
    Variation of PI-RADS Interpretations between Experts: A Significant Limitation.
    Radiology. 2020;296:85-86.
    PubMed    
    
    
    June 2020
25. ZHANG Z, Wu HH, Priester A, Magyar C, et al
    Prostate Microstructure in Prostate Cancer Using 3-T MRI with Diffusion-Relaxation Correlation Spectrum Imaging: Validation with Whole-Mount Digital Histopathology.
    Radiology. 2020 Jun 9:192330. doi: 10.1148/radiol.2020192330.
    PubMed     Abstract available
    
    
    May 2020
26. TAN N, Oyoyo U, Bavadian N, Ferguson N, et al
    PSMA-targeted Radiotracers versus (18)F Fluciclovine for the Detection of Prostate Cancer Biochemical Recurrence after Definitive Therapy: A Systematic Review and Meta-Analysis.
    Radiology. 2020 May 12:191689. doi: 10.1148/radiol.2020191689.
    PubMed     Abstract available
    
    
    
27. PADHANI AR, Petralia G
    Radiologists Should Integrate Clinical Risk Factors with MRI Findings for Meaningful Prostate Cancer Staging.
    Radiology. 2020 May 5:201082. doi: 10.1148/radiol.2020201082.
    PubMed    
    
    
    
28. PARK KJ, Kim MH, Kim JK
    Extraprostatic Tumor Extension: Comparison of Preoperative Multiparametric MRI Criteria and Histopathologic Correlation after Radical Prostatectomy.
    Radiology. 2020 May 5:192133. doi: 10.1148/radiol.2020192133.
    PubMed     Abstract available
    
    
    April 2020
29. WESTPHALEN AC, McCulloch CE, Anaokar JM, Arora S, et al
    Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel.
    Radiology. 2020 Apr 21:190646. doi: 10.1148/radiol.2020190646.
    PubMed     Abstract available
    
    
    
30. MEYRIGNAC O, Aziza R, Roumiguie M, Malavaud B, et al
    Closing the Gap between Prostate Cancer and Deep Learning Detection Tools.
    Radiology. 2020 Apr 14:200187. doi: 10.1148/radiol.2020200187.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: